{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-001223","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2023-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.970653+00:00","generated_at":"2026-06-20T17:20:39.901738+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Eterna Therapeutics transfers Nasdaq listing to Capital Market, effective Jan 11, 2023","bullets":["Nasdaq Staff approved transfer from Global Market to Capital Market on Jan 9, 2023.","Common stock begins trading on Capital Market at open on Jan 11, 2023 under symbol ERNA.","Company voluntarily applied for transfer on Jan 2, 2023 (previously reported).","Capital Market has similar corporate governance requirements but different financial listing standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-001223","json":"https://secwatch.observer/filing/0001140361-23-001223.json","markdown":"https://secwatch.observer/filing/0001140361-23-001223.md","text":"https://secwatch.observer/filing/0001140361-23-001223.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000114036123001223/0001140361-23-001223-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000114036123001223/brhc10046500_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:20:39.901738+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}